Literature DB >> 1491011

Identification of the disulfide bonds in human plasma protein SP-40,40 (apolipoprotein-J).

N H Choi-Miura1, Y Takahashi, Y Nakano, T Tobe, M Tomita.   

Abstract

SP-40,40, a human plasma protein, is a modulator of the membrane attack complex formation of the complement system as well as a subcomponent of high-density lipoproteins. In the present study, the positions of the disulfide bonds in SP-40,40 were determined. SP-40,40 was purified from human seminal plasma by affinity chromatography using an anti-SP-40,40 monoclonal antibody and reversed-phase, high-performance liquid chromatography (HPLC). The protein was digested with trypsin and the fragments were separated by reversed-phase HPLC. The peptides containing disulfide bonds were fluorophotometrically detected with 4-(aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole (ABD-F). The peptides containing more than two disulfide bonds were further digested with Staphylococcus aureus V8 protease and lysylendopeptidase, and the fragments were isolated by HPLC. The amino acid compositions and the amino acid sequences of the peptides containing only a disulfide bond were determined. Disulfide bonds thus determined were between Cys58(alpha)-Cys107(beta), Cys68(alpha)-Cys99(beta), Cys75(alpha)-Cys94(beta), and Cys86(alpha)-Cys80(beta). Since there was no free sulfhydryl groups in the SP-40,40 molecule, Cys78(alpha) and Cys91(beta) should also be linked by a disulfide bond. It is notable that all of the disulfide bonds in SP-40,40 are not only formed by inter-chain pairing, but also appear to form an antiparallel ladder-like structure between the two chains. The unique structure could be related to the functions of SP-40,40.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1491011     DOI: 10.1093/oxfordjournals.jbchem.a123938

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  15 in total

1.  Clusterin, a putative complement regulator, binds to the cell surface of Staphylococcus aureus clinical isolates.

Authors:  S R Partridge; M S Baker; M J Walker; M R Wilson
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

2.  Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.

Authors:  M Navab; S Hama-Levy; B J Van Lenten; G C Fonarow; C J Cardinez; L W Castellani; M L Brennan; A J Lusis; A M Fogelman; B N La Du
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

3.  Identification and characterization of glycosylation sites in human serum clusterin.

Authors:  J T Kapron; G M Hilliard; J N Lakins; M P Tenniswood; K A West; S A Carr; J W Crabb
Journal:  Protein Sci       Date:  1997-10       Impact factor: 6.725

Review 4.  A Role for Clusterin in Exfoliation Syndrome and Exfoliation Glaucoma?

Authors:  Janey L Wiggs; Jae Hee Kang; BaoJian Fan; Hani Levkovitch-Verbin; Louis R Pasquale
Journal:  J Glaucoma       Date:  2018-07       Impact factor: 2.503

5.  Hidden Aggregation Hot-Spots on Human Apolipoprotein E: A Structural Study.

Authors:  Paraskevi L Tsiolaki; Aikaterini D Katsafana; Fotis A Baltoumas; Nikolaos N Louros; Vassiliki A Iconomidou
Journal:  Int J Mol Sci       Date:  2019-05-08       Impact factor: 5.923

6.  Retrospective Case-Control Study of Apolipoprotein J/Clusterin Protein Expression in Early Liveborn Neonatal Deaths with and without Pontosubicular Necrosis.

Authors:  Kathreena M Kurian; Declan McGuone
Journal:  Patholog Res Int       Date:  2012-07-12

7.  Expression and purification of chaperone-active recombinant clusterin.

Authors:  Rebecca A Dabbs; Mark R Wilson
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

8.  Plasma clusterin (ApoJ) levels are associated with adiposity and systemic inflammation.

Authors:  Jong Chul Won; Cheol-Young Park; Sang Woo Oh; Eon Sook Lee; Byung-Soo Youn; Min-Seon Kim
Journal:  PLoS One       Date:  2014-07-30       Impact factor: 3.240

9.  Distinct Ultradian Rhythms in Plasma Clusterin Concentrations in Lean and Obese Korean Subjects.

Authors:  Jong Han Choi; Eunheui Jeong; Byung Soo Youn; Min Seon Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2018-05-04

Review 10.  Heat Shock Proteins and Ovarian Cancer: Important Roles and Therapeutic Opportunities.

Authors:  Abdullah Hoter; Hassan Y Naim
Journal:  Cancers (Basel)       Date:  2019-09-18       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.